Rep. Gilbert Ray Cisneros, Jr. Buys CME Group Inc. (NASDAQ:CME) Stock

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on January 9th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Banco Santander (NYSE:SAN) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Leonardo (OTCMKTS:FINMF) on 2/3/2026.
• Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of Transdigm Group (NYSE:TDG) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of Cloudflare (NYSE:NET) on 1/30/2026.
• Purchased $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 1/30/2026.

CME Group Price Performance

NASDAQ:CME traded up $0.16 on Tuesday, hitting $303.23. The company had a trading volume of 2,127,501 shares, compared to its average volume of 2,224,694. CME Group Inc. has a 52 week low of $244.43 and a 52 week high of $309.35. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $109.34 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 3.29 and a beta of 0.27. The firm has a 50 day moving average of $280.48 and a two-hundred day moving average of $274.14.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the business posted $2.52 EPS. CME Group’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s payout ratio is presently 44.80%.

Insider Activity

In other news, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William R. Shepard acquired 251 shares of the stock in a transaction dated Tuesday, December 30th. The stock was acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the transaction, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CME shares. Raymond James Financial reduced their price target on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Jefferies Financial Group cut their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research report on Monday, January 12th. Barclays boosted their price objective on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Argus lowered their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Finally, Bank of America increased their price target on CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $299.53.

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Caldwell Trust Co lifted its holdings in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Asset Dedication LLC grew its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in CME Group during the third quarter valued at approximately $27,000. FNY Investment Advisers LLC purchased a new stake in CME Group during the fourth quarter worth $27,000. Finally, Elkhorn Partners Limited Partnership purchased a new stake in CME Group during the fourth quarter worth $27,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.